Mitsubishi UFJ Kokusai Asset Management Co. Ltd. decreased its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 10.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,135 shares of the medical instruments supplier’s stock after selling 3,867 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in DENTSPLY SIRONA were worth $2,148,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of XRAY. Korea Investment CORP raised its position in DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after buying an additional 1,251 shares during the last quarter. Howard Hughes Medical Institute raised its position in DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 1,580 shares during the last quarter. Penserra Capital Management LLC increased its position in shares of DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 240 shares during the period. Howland Capital Management LLC purchased a new position in shares of DENTSPLY SIRONA during the first quarter worth approximately $203,000. Finally, IBM Retirement Fund increased its position in shares of DENTSPLY SIRONA by 29.9% in the second quarter. IBM Retirement Fund now owns 3,324 shares of the medical instruments supplier’s stock worth $216,000 after buying an additional 766 shares during the period. Hedge funds and other institutional investors own 95.13% of the company’s stock.

Shares of DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 53.76 on Wednesday. DENTSPLY SIRONA Inc. has a 1-year low of $53.21 and a 1-year high of $65.68. The stock’s market capitalization is $12.34 billion. The stock has a 50 day moving average of $62.34 and a 200-day moving average of $62.34.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. The company had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The firm’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period last year, the company earned $0.76 EPS. Equities research analysts predict that DENTSPLY SIRONA Inc. will post $2.72 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.0875 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.35 annualized dividend and a dividend yield of 0.65%. DENTSPLY SIRONA’s payout ratio is currently -10.09%.

COPYRIGHT VIOLATION NOTICE: “Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Sells 3,867 Shares of DENTSPLY SIRONA Inc. (XRAY)” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was stolen and republished in violation of US and international copyright laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/16/mitsubishi-ufj-kokusai-asset-management-co-ltd-sells-3867-shares-of-dentsply-sirona-inc-xray.html.

A number of brokerages have commented on XRAY. HC Wainwright reaffirmed a “buy” rating and set a $68.00 target price (down from $74.00) on shares of DENTSPLY SIRONA in a research note on Monday. Morgan Stanley lifted their target price on shares of DENTSPLY SIRONA from $66.00 to $67.00 and gave the stock an “overweight” rating in a research note on Thursday, August 10th. Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. TheStreet downgraded shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research note on Wednesday, August 9th. Finally, Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Wednesday, April 19th. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $66.25.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.